Vietnam is significantly expanding its cardiovascular care capabilities as rising rates of heart disease, increased healthcare investment and rapid adoption of advanced cardiac technologies drive demand for next-generation cardiovascular devices.
While a dedicated valuation for Vietnam's cardiovascular devices market has not yet been published, industry analysis estimates the market is currently worth US$320–420 million in 2025 and is projected to reach US$520–680 million by 2030.
The market includes a broad range of technologies supporting the diagnosis and treatment of cardiovascular disease, including coronary stents, pacemakers, implantable cardioverter-defibrillators (ICDs), heart valves, electrophysiology systems, catheters, ventricular assist devices (VADs), cardiac monitoring systems and structural heart implants.
Several long-term trends are driving growth across Vietnam:
- Rising prevalence of cardiovascular disease, hypertension and diabetes.
- An ageing population increasing demand for interventional cardiology procedures.
- Expansion of specialist cardiac hospitals and catheterisation laboratories.
- Greater adoption of minimally invasive cardiovascular interventions.
- Growing investment in cardiac imaging, remote patient monitoring and digital health technologies.
- Increasing use of artificial intelligence to support diagnosis and treatment planning.
- Government investment in expanding access to specialist cardiovascular care.
Cardiovascular disease remains one of Vietnam's leading causes of death, with approximately 200,000 cardiovascular-related deaths each year, highlighting the urgent need for expanded diagnostic and treatment capacity. This growing disease burden is driving increased demand for advanced cardiovascular devices across both public and private healthcare providers.
Investment in implantable cardiac technologies continues to grow. According to IMARC Group, Vietnam's implantable medical devices market reached US$604.4 million in 2025 and is projected to grow to US$1.11 billion by 2034, with cardiovascular implants representing one of the largest product categories. These include coronary stents, heart valves, pacemakers and implantable defibrillators, all of which are benefiting from increasing procedure volumes and broader access to advanced cardiac care.
Demand for advanced heart failure therapies is also increasing. IMARC Group reports that Vietnam's ventricular assist devices (VAD) market reached US$11.34 million in 2025 and is expected to grow to US$22.03 million by 2034, reflecting expanding surgical expertise and wider availability of mechanical circulatory support for patients with end-stage heart failure.
Technology is rapidly transforming cardiovascular care. Modern devices increasingly integrate artificial intelligence, remote monitoring, wearable sensors and advanced imaging to improve diagnosis, treatment planning and long-term disease management. Minimally invasive procedures such as transcatheter aortic valve replacement (TAVR), catheter-based ablation and percutaneous coronary intervention (PCI) continue to replace traditional open-heart surgery in many clinical settings. These advances are improving patient outcomes while reducing recovery times and hospital stays.
Globally, the cardiovascular devices market continues to expand. IMARC Group estimates the market reached US$65.8 billion in 2025 and will grow to US$106.4 billion by 2034, driven by increasing cardiovascular disease prevalence, technological innovation and greater adoption of minimally invasive cardiac procedures.
Leading manufacturers including Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, GE HealthCare, Philips, Siemens Healthineers, Biotronik, Terumo and Johnson & Johnson MedTech continue to invest in next-generation cardiovascular technologies spanning diagnostics, structural heart interventions, electrophysiology and remote cardiac monitoring.
As Vietnam continues to modernise its healthcare system and strengthen cardiovascular services, advanced cardiac technologies are expected to play an increasingly important role in improving patient outcomes and reducing the burden of heart disease. For manufacturers of cardiovascular implants, diagnostic equipment, monitoring technologies and interventional devices, Vietnam represents one of Southeast Asia's most promising long-term growth markets.